Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Mol Cancer Res. 2018 Jul 10;16(10):1470–1482. doi: 10.1158/1541-7786.MCR-18-0322

Figure 1. LINC00152 is upregulated in aggressive gliomas and in many cancer types.

Figure 1

A) Boxplot of LINC00152 expression in normal brain tissue, G2 (grade 2 glioma), G3 (grade 3 glioma) and GBM. B) Boxplot of LINC00152 expression in LGG subtypes and normal brain tissue. C – L) Expression (RSEM) of LINC00152 in tumors and matched normal tissue from the TCGA in head and neck squamous carcinoma, renal papillary tumor, hepatocellular carcinoma, colorectal carcinoma, renal clear cell carcinoma, breast invasive carcinoma, stomach adenocarcinoma, uterine carcinoma, thyroid carcinoma and lung adenocarcinoma, respectively.